Treatment de-escalation in inflammatory bowel diseases

被引：0
|
作者：
Abitbol, Vered [1 ]
机构：
[1] Hop Cochin, Serv Gastroenterol, 27 Rue Faubourg St Jacques, F-75014 Paris, France
来源：
PRESSE MEDICALE | 2018年 / 47卷 / 11-12期
关键词：
THERAPY; WITHDRAWAL; INFLIXIMAB; CROHNS; AZATHIOPRINE; MAINTENANCE;
D O I：
10.1016/j.lpm.2018.11.015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：931 / 933
页数：3
相关论文
共 50 条
  • [1] De-escalation of Therapy in Inflammatory Bowel Disease
    Frias Gomes C.
    Colombel J.-F.
    Torres J.
    [J]. Current Gastroenterology Reports, 2018, 20 (8)
  • [2] De-escalation of Biologic Treatment in Inflammatory Bowel Disease: A Comprehensive Review
    Gisbert, Javier P.
    Chaparro, Maria
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 (04): : 642 - 658
  • [3] De-escalation of medical therapy in inflammatory bowel disease
    Gomes, Catarina Frias
    Chapman, Thomas P.
    Satsangi, Jack
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2020, 55 : 73 - 81
  • [4] Predictors of sustained remission after infliximab de-escalation in patients with inflammatory bowel diseases
    Kantasiripitak, W.
    Outtier, A.
    Thomas, D.
    Sabino, J.
    Vermeire, S.
    Ferrante, M.
    Dreesen, E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I485 - I485
  • [5] Predictors of sustained remission after infliximab de-escalation in patients with inflammatory bowel diseases
    Kantasiripitak, W.
    Outtier, A.
    Thomas, D.
    Sabino, J.
    Vermeire, S.
    Ferrante, M.
    Dreesen, E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I485 - I485
  • [6] De-escalation of Therapy in Patients with Quiescent Inflammatory Bowel Disease
    Miyatani, Yusuke
    Kobayashi, Taku
    [J]. GUT AND LIVER, 2023, 17 (02) : 181 - 189
  • [7] De-escalation of immunomodulator and biological therapy in inflammatory bowel disease
    Chapman, Thomas P.
    Gomes, Catarina Frias
    Louis, Edouard
    Colombel, Jean-Frederic
    Satsangi, Jack
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (01): : 63 - 79
  • [8] De-escalation of biological therapy in Inflammatory Bowel Disease patients following prior escalation
    Thomas, P.
    Smits, L.
    Groen, M. Te
    West, R.
    Russel, M.
    Jansen, J.
    Romkens, T.
    Hoentjen, F.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S086 - S086
  • [9] Pharmacokinetic Parameters of Infliximab Influence the Rate of Relapse After De-Escalation in Adults With Inflammatory Bowel Diseases
    Petitcollin, Antoine
    Brochard, Charlene
    Siproudhis, Laurent
    Tron, Camille
    Verdier, Marie-Clemence
    Lemaitre, Florian
    Lucidarme, Camille
    Bouguen, Guillaume
    Bellissant, Eric
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (03) : 605 - 615
  • [10] De-escalation of Combination Drug Therapy in Inflammatory Bowel Disease Patients
    Saleh, Adam A.
    Waghela, Rajdeepsingh
    Garza, Manuel
    Stading, Rachel
    Miroballi, Natalia
    Moskow, Joshua
    Thurston, Theresa
    Abraham, Bincy
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S722 - S722
12345